The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Osteosarcoma of the spine: Experience of the Cooperative Osteosarcoma Study Group
Open accessAbstract
BACKGROUND: Due to the low incidence rate, the optimal strategy for the treatment of patients with spinal osteosarcoma is unknown. METHODS: Twenty‐two patients with osteosarcoma of the spine (15 with tumors of the sacrum and 7 with tumors at other sites) who received chemotherapy according to the Cooperative Osteosarcoma Study Group protocol were analyzed. Six patients presented with metastasis, and 16 patients had no evidence of metastasis at the time of entry into the protocol. Of 12 patients who underwent excision of their tumors, 2 patients underwent wide excision, 3 patients underwent marginal excision, and 7 patients underwent intralesional excision. Eight patients received irradiation: Six patients received conventional radiotherapy only, one patient received neutron beam therapy, and one patient received samarium‐153‐ethylene diamine tetramethylene phosphonate therapy. Follow‐up ranged between 24 months and 105 months (median, 47 months). RESULTS: The median survival was 23 months, and three patients have survived without disease for > 6 years. Patients with primary metastases (P = 0.004), large tumors (P = 0.010), and sacral tumors (P = 0.048) had lower overall survival compared with patients who had no metastasis, small tumors, and nonsacral tumors, respectively. There was a significant difference in overall survival between 5 patients who underwent either wide or marginal surgery and 17 patients who underwent either intralesional surgery or no surgery (P = 0.033). Among 17 patients who underwent no surgery or intralesional surgery, overall survival tended to be better in 7 patients who received irradiation compared with the overall survival in 10 patients who did not receive irradiation (P = 0.059). CONCLUSIONS: Patients with metastases, a large tumors, and sacral tumors had a poor prognosis in the current study with small numbers of patients. Wide or marginal excision of the tumor improved survival. Patients with osteosarcoma of the spine should be treated with a combination of chemotherapy and at least marginal excision for those with surgically accessible tumors. Postoperative radiotherapy may be beneficial. Cancer 2002;94:1069–77. © 2002 American Cancer Society. DOI 10.1002/cncr.10258
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A System for the Surgical Staging of Musculoskeletal Sarcoma
ENNEKING, W. F., SPANIER, S. S., & GOODMAN, M. A. (1980) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198011000-00013 · Cited by 2,500
A system for the surgical staging of musculoskeletal sarcoma.
Enneking, W. F., Spanier, S. S., & Goodman, M. A. (1981) · PubMed · Cited by 1,001
Winkler, K., Beron, G., Delling, G., Heise, U., Kabisch, H., Purfürst, C., Berger, J., Ritter, J., Jürgens, H., & Gerein, V (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.2.329 · Cited by 459
Self-citationDahlin's Bone Tumors. General Aspects and Data on 11,087 Cases
Devaney, K. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199610000-00019 · Cited by 439
Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study.
Winkler, K., Beron, G., Kotz, R., Salzer-Kuntschik, M., Beck, J., Beck, W., Brandeis, W., Ebell, W., Erttmann, R., & Göbel, U. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.6.617 · Cited by 345
Self-citationEvaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET.
Schulte, M., Brecht-Krauß, D., Werner, M., Hartwig, E., Sarkar, M. R., Keppler, P., Kotzerke, J., Guhlmann, A., Delling, G., & Reske, S. N. (1999) · PubMed · Cited by 198
Self-citationInterval between symptom onset and diagnosis of pediatric solid tumors
Pollock, B. H., Krischer, J. P., & Vietti, T. J. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80287-2 · Cited by 176
Salzer-Kuntschik, M., Brand, G., & Delling, G. (1983) · PubMed · Cited by 162
Self-citationWinkler, K., Bielack, S., Delling, G., Salzer-Kuntschik, M., Kotz, R. I., Greenshaw, C., Jürgens, H., Ritter, J., Kusnierz-Glaz, C. R., Erttmann, R., et al. (1990) · Cancer · Cited by 146
Self-citationOsteogenic sarcoma of the extremity with detectable lung metastases at presentation
Bacci, G., Mercuri, M., Briccoli, A., Ferrari, S., Bertoni, F., Donati, D. M., Monti, C., Zanoni, A., Forni, C., & Manfrini, M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970115)79:2<245::aid-cncr7>3.0.co;2-j · Cited by 122
Cited by
Osteosarcoma treatment – Where do we stand? A state of the art review
Luetke, A., Meyers, P. A., Lewis, I., & Juergens, H. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.11.006 · Cited by 1,234
Ritter, J., & Bielack, S. S. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq276 · Cited by 1,045
Self-citationKempf-Bielack, B., Bielack, S. S., Jürgens, H., Branscheid, D., Berdel, W. E., Exner, G. U., Göbel, U., Helmke, K., Jundt, G., Kabisch, H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.063 · Cited by 643
Self-citationOsteosarcoma: a comprehensive review
Misaghi, A., Goldin, A., Awad, M., & Kulidjian, A. A. (2018) · SICOT-J · doi:10.1051/sicotj/2017028 · Cited by 517
Diagnostic Imaging of Solitary Tumors of the Spine: What to Do and Say
Rodallec, M. H., Feydy, A., Larousserie, F., Anract, P., Campagna, R., Babinet, A., Zins, M., & Drapé, J.-L. (2008) · RadioGraphics · doi:10.1148/rg.284075156 · Cited by 360
Osteosarcoma treatment: state of the art
Ta, H. T., Dass, C. R., Choong, P. F. M., & Dunstan, D. E. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-009-9186-7 · Cited by 314
Radiotherapy for local control of osteosarcoma
DeLaney, T. F., Park, L., Goldberg, S. I., Hug, E. B., Liebsch, N. J., Munzenrider, J. E., & Suit, H. D. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.05.051 · Cited by 306
Duchman, K. R., Gao, Y., & Miller, B. J. (2015) · Cancer Epidemiology · doi:10.1016/j.canep.2015.05.001 · Cited by 305
En bloc resection of primary sacral tumors: classification of surgical approaches and outcome
Fourney, D. R., Rhines, L. D., Hentschel, S. J., Skibber, J. M., Wolinsky, J.-P., Weber, K. L., Suki, D., Gallia, G. L., Garonzik, I., & Gokaslan, Z. L. (2005) · Journal of Neurosurgery: Spine · doi:10.3171/spi.2005.3.2.0111 · Cited by 291
Sandberg, A. A., & Bridge, J. A. (2003) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(03)00105-5 · Cited by 262
Proton‐based radiotherapy for unresectable or incompletely resected osteosarcoma
Ciernik, I. F., Niemierko, A., Harmon, D. C., Kobayashi, W., Chen, Y., Yock, T. I., Ebb, D. H., Choy, E., Raskin, K. A., Liebsch, N., et al. (2011) · Cancer · doi:10.1002/cncr.26037 · Cited by 191
Impact of carbon ion radiotherapy for unresectable osteosarcoma of the trunk
Matsunobu, A., Imai, R., Kamada, T., Imaizumi, T., Tsuji, H., Tsujii, H., Shioyama, Y., Honda, H., Tatezaki, S., & for the Working Group for Bone and Soft Tissue Sarcomas (2012) · Cancer · doi:10.1002/cncr.27451 · Cited by 158
Sulzbacher, I., Birner, P., Trieb, K., Träxler, M., Lang, S., & Chott, A. (2003) · Modern Pathology · doi:10.1097/01.mp.0000043522.76788.0a · Cited by 81
Metadata
- Authors
- Ozaki, T., Flege, S., Liljenqvist, U., Hillmann, A., Delling, G., Salzer‐Kuntschik, M., Jürgens, H., Kotz, R., Winkelmann, W., & Bielack, S. S.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2002-02-15
- Volume
- 94
- Issue
- 4
- Pages
- 1069-1077
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2014055476
- Cited by
- 283
- References
- 15
- FWCI
- 7.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.